Palvella Therapeutics, Inc. PVLA
142.85 USD -2.92 (-2.00%)
Regular-session close
142.85 0.00 0.00%
After hours · Nov 20, 4:26 PM ET
142.22 Day range 148.69
76.43 52-week range 175.92
- YTD
- +36.48%
- 1 year
- +56.05%
Held by funds
87 US ETFs and mutual funds hold PVLA · largest positions
- XBI 0.62% of fund $64.89M
- IWM 0.07% of fund $54.02M
- VTI 0.00% of fund $53.86M
- FIDGX 0.25% of fund $22.64M
- NJM 0.03% of fund $21.07M
- IWO 0.14% of fund $19.64M
- VXF 0.02% of fund $19.08M
- FSSNX 0.05% of fund $18.35M
- SCHA 0.05% of fund $11.89M
- VTWO 0.05% of fund $9.55M
- FSMAX 0.02% of fund $7.76M
- SHSSX 0.11% of fund $7.00M
- NLO 0.05% of fund $6.81M
- VEXRX 0.02% of fund $5.17M
- VHT 0.02% of fund $4.38M
- PTH 1.46% of fund $4.30M
- DWAS 0.99% of fund $3.90M
- FSKAX 0.00% of fund $3.31M
- MDSKX 0.06% of fund $3.20M
- LFSC 2.40% of fund $3.14M
Ownership
Held by insiders 11.05%
Held by institutions 105.02%
Float held by institutions 118.07%
Institutions 277
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Jennison Associates LLC | 7.54% | 1,101,652 | 157.37M | Sep 29, 2026 |
| Montanova Capital LLC | 7.15% | 1,044,898 | 149.26M | Sep 29, 2026 |
| Blackrock Inc. | 6.77% | 989,691 | 141.38M | Sep 29, 2026 |
| Frazier Life Sciences Management, L.P. | 6.04% | 882,400 | 126.05M | Sep 29, 2026 |
| First Light Asset Management, LLC | 5.02% | 734,086 | 104.86M | Sep 29, 2026 |
| State Street Corporation | 4.27% | 624,879 | 89.26M | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.66% | 388,390 | 55.48M | Jun 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.48% | 362,314 | 51.76M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.11% | 308,699 | 44.10M | Sep 29, 2026 |
| Federated Hermes Equity Funds-Federated Hermes Kaufmann Fund | 1.89% | 276,556 | 39.51M | Jul 30, 2026 |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 1.58% | 231,484 | 33.07M | Jun 29, 2026 |
| PRIMECAP Odyssey Funds-PRIMECAP Odyssey Aggressive Growth Fund | 1.45% | 212,225 | 30.32M | Sep 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| GOIN KATHLEEN | Chief Operating Officer | Sale | Aug 18, 2026 | 0 |
| HERON ELAINE J | Director | Purchase | Feb 26, 2026 | 53,691 |
| JENKINS GEORGE M | Director | Sale | Oct 13, 2026 | 146,132 |
| KIRITSY CHRISTOPHER P | Director | Sale | Sep 1, 2026 | 250 |
| KORENBERG MATTHEW E | Chief Financial Officer | Conversion of Exercise of derivative security | Jun 11, 2026 | 1,000 |
| MARTINI JEFFREY | Officer | Sale | Nov 10, 2026 | 0 |
